Anticoagulation for cerebral venous sinus thrombosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anticoagulation for Cerebral Venous Sinus Thrombosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433665/all/Anticoagulation_for_cerebral_venous_sinus_thrombosis.
Anticoagulation for cerebral venous sinus thrombosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433665/all/Anticoagulation_for_cerebral_venous_sinus_thrombosis. Accessed December 5, 2025.
Anticoagulation for cerebral venous sinus thrombosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433665/all/Anticoagulation_for_cerebral_venous_sinus_thrombosis
Anticoagulation for Cerebral Venous Sinus Thrombosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433665/all/Anticoagulation_for_cerebral_venous_sinus_thrombosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anticoagulation for cerebral venous sinus thrombosis
ID - 433665
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433665/all/Anticoagulation_for_cerebral_venous_sinus_thrombosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

